NATIONAL HEALTH INVESTORS INC - COMMON STOCK (NHI)

CUSIP: 63633D104

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
+36,658
Put/Call ratio
2.2%
SEC-reported price per share
$80.86
Number of holders
318
Value change
+$8,409,601
Number of buys
166
Open additional details 1 more signal available
Number of sells
119
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
48,856,018

Security key

63633D104

Report period

Q1 2026

Institutions

318

Top holders

10

Ownership snapshot

Top reported holders of NHI - NATIONAL HEALTH INVESTORS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD CAPITAL MANAGEME...
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G 3/4/5 13F Lead comparable stake: 5.1% 13D/G row: VANGUARD CAPITAL MANAGEMENT LLC Showing 1-6 of 15 holder rows.

Quick read

VANGUARD CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 5.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership Top 5
VANGUARD CAPITAL MANAGEMENT LLC 5.1%
ADAMS ROBERT G 1.2%
SWAFFORD CHARLOTTE A 0.26%
Kevin Carlton Pascoe 0.15%
Tracy M. J. Colden 0.03%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD CAPITAL MANAGEMENT LLC
13D/G
Vanguard Capital Management
5.1%
$200,182,757
2,475,671 shares
$0 31 Mar 2026
ADAMS ROBERT G
3/4/5
Director
1.2%
$43,795,116
566,551 shares
— 27 Jan 2026
SWAFFORD CHARLOTTE A
3/4/5
Director
0.26%
$9,981,046
127,358 shares
— 09 Dec 2025
Kevin Carlton Pascoe
3/4/5
Chief Investment Officer
0.15%
$5,581,272
73,082 shares
— 03 Mar 2026
Tracy M. J. Colden
3/4/5
Director
0.03%
$1,055,898
12,858 shares
— 03 Mar 2026
Candice W. Todd
3/4/5
Director
0.01%
$210,473
2,563 shares
— 03 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
318
Shares
34,549,986
Rows available
318
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
318
Q1 2026 holders
318
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .